Monocyte derived dendritic cells retain their functional capacity in patients following infection with hepatitis C...

Area of Science:

• Immunology
• Virology
• Cell Biology

Background:

• Conflicting results exist regarding monocyte-derived dendritic cell (MD-DC) function in hepatitis C virus (HCV) infection.
• Understanding MD-DC function is crucial for elucidating HCV pathogenesis and developing autologous MD-DC-based vaccination strategies.

Purpose of the Study:

• To determine the allostimulatory capacity of MD-DC before and after HCV infection.
• To compare the phenotype, cytokine production, and allostimulatory function of MD-DC from HCV-infected individuals with those from healthy controls.
• To assess the ability of MD-DC to prime autologous peptide-specific CD8+ T cells.

Main Methods:

• Assessed MD-DC allostimulatory capacity in the same patient pre- and post-HCV infection.
• Compared phenotype, IL-10, and IL-12(p70) production of immature and mature MD-DC from HCV-infected and healthy individuals.
• Evaluated MD-DC ability to prime peptide-specific CD8+ T cells using HLA-A2 class-I tetramers.

Main Results:

• MD-DC maintained consistent allostimulatory capacity before and after persistent HCV infection.
• No significant differences were observed in MD-DC surface phenotype or IL-10/IL-12(p70) production between HCV-infected and healthy individuals.
• Mature MD-DC from HCV-infected individuals showed comparable allogeneic mixed lymphocyte reaction (MLR) performance and effectively stimulated peptide-specific CD8+ T cell expansion.

Conclusions:

• MD-DC from individuals with persistent HCV infection are phenotypically indistinguishable from those of healthy controls.
• MD-DC function, including allostimulatory capacity and T cell priming, is preserved in HCV infection.
• These findings suggest that MD-DC retain functional competence in the context of chronic HCV infection.